| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/01/1997 | WO1997015318A1 Peptide inhibitors of a phosphotyrosine-binding domain containing protein |
| 05/01/1997 | WO1997015317A1 GnRH/REDUCED PSEUDOMONAS EXOTOXIN CONJUGATES |
| 05/01/1997 | WO1997015316A1 Conjugates of gonadotropin releasing hormone |
| 05/01/1997 | WO1997015315A1 Localized intravascular delivery of tfpi for inhibition of restenosis in recanalized blood vessels |
| 05/01/1997 | WO1997015313A1 Therapeutic use of hemoglobin in promoting wound healing |
| 05/01/1997 | WO1997015310A1 In vitro growth of functional islets of langerhans and in vivo uses thereof |
| 05/01/1997 | WO1997015309A1 Method of inhibiting sleep apnea |
| 05/01/1997 | WO1997015304A1 Use of 1-(2-naphth-2-ylethyl)-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine for preparing drugs for treating amyotrophic lateral sclerosis |
| 05/01/1997 | WO1997015301A1 Method of adjusting the circadian rhythm of a mammal |
| 05/01/1997 | WO1997015297A1 Compositions and methods for buccal delivery of pharmaceutical agents |
| 05/01/1997 | WO1997015296A1 Buccal delivery of glucagon-like insulinotropic peptides |
| 05/01/1997 | WO1997015289A1 Solubilisation methods |
| 05/01/1997 | WO1997015288A2 Method and preparations for stabilizing biological materials by drying methods without freezing |
| 05/01/1997 | WO1997015287A1 Thermosensitive biodegradable polymers based on poly(ether-ester) block copolymers |
| 05/01/1997 | WO1997015280A1 Use of at least one no synthase inhibitor for treating sensitive skin |
| 05/01/1997 | WO1997015269A2 Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents |
| 05/01/1997 | WO1997015195A1 Hybrid matrix implants and explants |
| 05/01/1997 | WO1997015190A1 Thrombin inhibitors |
| 05/01/1997 | WO1997012601A3 Gel formulations containing growth factors |
| 05/01/1997 | WO1997012527A3 Use of threonine for the treatment of phenylketonuria |
| 05/01/1997 | WO1997009430A3 A human metalloproteinase, variants thereof and dna sequences codding therefor |
| 05/01/1997 | CA2238940A1 Luminal cholecystokinin-releasing factor |
| 05/01/1997 | CA2235854A1 Method of inhibiting sleep apnea |
| 05/01/1997 | CA2235832A1 Microporous pathogen-killing composition |
| 05/01/1997 | CA2235803A1 Method of adjusting the circadian rhythm of a mammal |
| 05/01/1997 | CA2235756A1 Peptide inhibitors of a phosphotyrosine-binding domain containing protein |
| 05/01/1997 | CA2235685A1 Hyaluronic acid as dna carrier for gene therapy and vegf antisense dna to treat abnormal retinal vascularization |
| 05/01/1997 | CA2235602A1 Preparation of peptide containing biodegradable microspheres by melt process |
| 05/01/1997 | CA2235599A1 High fluorescence specific immune enhancing factor and methods of use for same |
| 05/01/1997 | CA2235575A1 Novel human cysteine protease |
| 05/01/1997 | CA2235548A1 Therapeutic use of hemoglobin in promoting wound healing |
| 05/01/1997 | CA2235511A1 Process for the preparation of a growth hormone secretagogue |
| 05/01/1997 | CA2235510A1 Gnrh/reduced pseudomonas exotoxin conjugates |
| 05/01/1997 | CA2235509A1 In vitro growth of functional islets of langerhans and in vivo uses thereof |
| 05/01/1997 | CA2235487A1 Solubilisation methods |
| 05/01/1997 | CA2235462A1 Method of mobilizing hematopoietic stem cells |
| 05/01/1997 | CA2235402A1 Compositions and methods for buccal delivery of pharmaceutical agents |
| 05/01/1997 | CA2235371A1 Polymorphic forms of a growth hormone secretagogue |
| 05/01/1997 | CA2235369A1 Buccal delivery of glucagon-like insulinotropic peptides |
| 05/01/1997 | CA2235368A1 Method and reagent for the treatment of diseases or conditions related to levels of vascular endothelial growth factor receptor |
| 05/01/1997 | CA2235360A1 Novel chemokine for mobilizing stem cells |
| 05/01/1997 | CA2233860A1 Thrombin inhibitors |
| 05/01/1997 | CA2232241A1 Diagnosis of susceptibility to cancer and treatment thereof |
| 05/01/1997 | CA2231245A1 Hemoglobin mutants that reduce heme loss |
| 05/01/1997 | CA2228054A1 Lubeluzole n-oxide |
| 05/01/1997 | CA2207846A1 Antitumor agents isolated from intestinal mucosa, a method for their isolation and their application |
| 05/01/1997 | CA2205534A1 Method, compositions and kits for increasing the bioavailability of pharmaceutical agents |
| 05/01/1997 | CA2204906A1 Neurotrophin antagonists |
| 05/01/1997 | CA2188381A1 Glycomimetics as selectin antagonists and pharmaceuticals having antiin flammatory activity |
| 04/30/1997 | DE19613606C1 Gene for hypertension present on chromosome 12p |
| 04/30/1997 | DE19539574A1 Zubereitungen und Verfahren zur Stabilisierung biologischer Materialien mittels Trocknungsverfahren ohne Einfrieren Compositions and methods for stabilizing biological materials by means of drying processes without freezing |
| 04/30/1997 | CN1148624A Reformed human tumor necrosin derivative and preparation method thereof |
| 04/30/1997 | CN1148505A Activated immune globulin |
| 04/30/1997 | CN1148504A Fibrin freeze-dried drops and preparation method thereof |
| 04/30/1997 | CN1148503A Application of noval peptidic compound in preparation of medicine |
| 04/30/1997 | CN1034735C Hemoregulating peptides |
| 04/30/1997 | CN1034733C Spiro piperidines and homologs which promote release of growth hormone |
| 04/29/1997 | US5625126 Transgenic non-human animals for producing heterologous antibodies |
| 04/29/1997 | US5625072 Retroviral protease inhibiting compounds |
| 04/29/1997 | US5625066 Optically active hydroquinine (amino-3 phenyl)-1 ethanesulfonate, preparation and use thereof |
| 04/29/1997 | US5625040 Phosphacan: a chondroitin sulfate proteoglycan of brain that interacts with neurons and neural cell adhesion molecules |
| 04/29/1997 | US5625038 Monoclonal antibodies specific for Erysipelothrix rhusiopathiae |
| 04/29/1997 | US5625035 Erythropoietin binding protein from mammalian serum |
| 04/29/1997 | US5625032 Selective amylin antagonist peptides and uses therefor |
| 04/29/1997 | US5625031 Peptide inhibitors of the p33cdk2 and p34cdc2 cell cycle regulatory kinases and human papillomavirus E7 oncoprotein |
| 04/29/1997 | US5624946 Use of leflunomide to control and reverse chronic allograft rejection |
| 04/29/1997 | US5624939 N-acyl pyrrolidines and drugs for the treatment or prevention of cholecystokinin and gastrin-related disorders |
| 04/29/1997 | US5624936 Inhibitors of farnesyl-protein transferase |
| 04/29/1997 | US5624921 Hypotriglyceridemic aminoacetylmercapto derivatives |
| 04/29/1997 | US5624912 Method of treating HIV infection and related secondary infections with defibrotide |
| 04/29/1997 | US5624905 Merosin fragments and uses thereof |
| 04/29/1997 | US5624904 Method for treating gram positive septicemia |
| 04/29/1997 | US5624903 Phosphoinositol-glycan-peptide with insulin-like action |
| 04/29/1997 | US5624902 Peptide inhibitors of calmodulin |
| 04/29/1997 | US5624900 High binding activity for human interleukin-1; treating rheumatoid arthritis |
| 04/29/1997 | US5624899 Ligands and proteins |
| 04/29/1997 | US5624898 Method for administering neurologic agents to the brain |
| 04/29/1997 | US5624897 Parasiticides, nematosides of cyclic peptide lactones for veterinary medicine |
| 04/29/1997 | US5624895 Treatment and/or prevention of type I diabetes mellitus with gamma interferon administration |
| 04/29/1997 | US5624894 Brain-enhanced delivery of neuroactive peptides by sequential metabolism |
| 04/29/1997 | US5624893 Pharmaceutical compositions and methods of treatment of the cornea following laser irradiation |
| 04/29/1997 | US5624837 Nucleic acid encoding chimeric complement inhibitor proteins |
| 04/29/1997 | US5624830 Selectivity killing mammalian host cells in vitro |
| 04/29/1997 | US5624827 DNA sequences encoding the plant toxin gelonin |
| 04/29/1997 | US5624823 DNA encoding procine interleukin-10 |
| 04/29/1997 | US5624820 Episomal expression vector for human gene therapy |
| 04/29/1997 | US5624817 Mutations in the gene encoding the alpha chain of platelet glycoprotein Ib |
| 04/29/1997 | US5624816 Transmembrane glycoprotein ASGP-2: nucleotide sequences and recombinant production of proteins |
| 04/29/1997 | US5624807 Methods for detecting Alzheimer's disease by measuring ratios of calcium-activated neutral protease isoforms |
| 04/29/1997 | US5624806 Antibodies to cardiac hypertrophy factor and uses thereof |
| 04/29/1997 | US5624805 Measuring the level of unbound somatomedins in human fluids |
| 04/29/1997 | US5624804 Glycosylation of protein such as albumin for medical diagnosis |
| 04/29/1997 | US5624684 Enzyme systems |
| 04/29/1997 | US5624678 Method and composition for treatment and/or prophylaxis of coccidiosis |
| 04/29/1997 | US5624670 Use of interleukin-8 for inducing cervical ripening |
| 04/24/1997 | WO1997014966A1 Method of activating a novel ligand regulatory pathway |
| 04/24/1997 | WO1997014808A2 Herpesvirus vectors and their uses |
| 04/24/1997 | WO1997014806A2 Delivery of biologically active polypeptides |
| 04/24/1997 | WO1997014802A1 Novel adherence factors of non pathogenic microorganisms and applications thereof for screening microorganisms for specific probiotic properties; novel pharmaceutical compositions and food additives comprising such microorganisms and adherence factors |
| 04/24/1997 | WO1997014801A1 Novel cell surface protein compounds |